Evidence map›Paper›PMID 27660613›Full record

ArticleFrontiers in physiology2016

Multiparametric Magnetic Resonance Investigation of Brain Adaptations to 6 Days at 4350 m.

Samuel Verges, Thomas Rupp, Marjorie Villien, Laurent Lamalle, Irène Troprés, Camille Poquet, Jan M Warnking, François Estève, Pierre Bouzat, Alexandre Krainik

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Samuel VergesHP2 Laboratory, Université Grenoble AlpesGrenoble, France; U1042, Institut National de la Santé et de la Recherche MédicaleGrenoble, France.
Thomas RuppHP2 Laboratory, Université Grenoble AlpesGrenoble, France; U1042, Institut National de la Santé et de la Recherche MédicaleGrenoble, France; Inter-Universitary Laboratory of Human Movement Biology, Université Savoie Mont BlancChambéry, France.
Marjorie VillienGrenoble Institute of Neurosciences, Université Grenoble AlpesGrenoble, France; SFR1, Université Grenoble AlpesGrenoble, France.
Laurent LamalleU836, Institut National de la Santé et de la Recherche Médicale Grenoble, France.
Irène TroprésU836, Institut National de la Santé et de la Recherche Médicale Grenoble, France.
Camille PoquetGrenoble Institute of Neurosciences, Université Grenoble AlpesGrenoble, France; SFR1, Université Grenoble AlpesGrenoble, France.
Jan M WarnkingGrenoble Institute of Neurosciences, Université Grenoble AlpesGrenoble, France; SFR1, Université Grenoble AlpesGrenoble, France.
François EstèveGrenoble Institute of Neurosciences, Université Grenoble AlpesGrenoble, France; SFR1, Université Grenoble AlpesGrenoble, France.
Pierre BouzatGrenoble Institute of Neurosciences, Université Grenoble AlpesGrenoble, France; SFR1, Université Grenoble AlpesGrenoble, France.
Alexandre KrainikGrenoble Institute of Neurosciences, Université Grenoble AlpesGrenoble, France; SFR1, Université Grenoble AlpesGrenoble, France.
Grenoble Institute of Neurosciences · FRUniversité Grenoble Alpes · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveHypoxic exposure in healthy subjects can induce acute mountain sickness including headache, lethargy, cerebral dysfunction, and substantial cerebral structural alterations which, in worst case, can lead to potentially fatal high altitude cerebral edema. Within this context, the relationships between high altitude-induced cerebral edema, changes in cerebral perfusion, increased brain parenchyma volume, increased intracranial pressure, and symptoms remain unclear.

methodsIn 11 subjects before and after 6 days at 4350 m, we performed multiparametric magnetic resonance investigations including anatomical, apparent diffusion coefficient and arterial spin labeling sequences.

resultsAfter the altitude stay, while subjects were asymptomatic, white matter volume (+0.7 ± 0.4%, p = 0.005), diffusion (+1.7 ± 1.4%, p = 0.002), and cerebral blood flow (+28 ± 38%; p = 0.036) were significantly increased while cerebrospinal fluid volume was reduced (-1.4 ± 1.1%, p = 0.009). Optic nerve sheath diameter (used as an index of increased intracranial pressure) was unchanged from before (5.84 ± 0.53 mm) to after (5.92 ± 0.60 mm, p = 0.390) altitude exposure. Correlations were observed between increases in white matter volume and diffusion (rho = 0.81, p = 0.016) and between changes in CSF volume and changes in ONSD s (rho = -0.92, p = 0.006) and symptoms during the altitude stay (rho = -0.67, p = 0.031).

conclusionsThese data demonstrate white matter alterations after several days at high altitude when subjects are asymptomatic that may represent the normal brain response to prolonged high altitude exposure.

Indexed as

altitudebrain volumecerebral blood flowdiffusionhypoxiaintracranial pressure

Identifiers

PMID27660613
PMCPMC5014870
OpenAlexW2516062277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.